Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials

BACKGROUND: Molecularly-guided trials (i.e. PMed) now seek to aid clinical decision-making by matching cancer targets with therapeutic options. Progress has been hampered by the lack of cancer models that account for individual-to-individual heterogeneity within and across cancer types. Naturally oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Paoloni, Melissa, Webb, Craig, Mazcko, Christina, Cherba, David, Hendricks, William, Lana, Susan, Ehrhart, E. J., Charles, Brad, Fehling, Heather, Kumar, Leena, Vail, David, Henson, Michael, Childress, Michael, Kitchell, Barbara, Kingsley, Christopher, Kim, Seungchan, Neff, Mark, Davis, Barbara, Khanna, Chand, Trent, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956546/
https://www.ncbi.nlm.nih.gov/pubmed/24637659
http://dx.doi.org/10.1371/journal.pone.0090028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956546/
https://www.ncbi.nlm.nih.gov/pubmed/24637659
http://dx.doi.org/10.1371/journal.pone.0090028

Ejemplares similares